DE69826521D1 - Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien - Google Patents

Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien

Info

Publication number
DE69826521D1
DE69826521D1 DE69826521T DE69826521T DE69826521D1 DE 69826521 D1 DE69826521 D1 DE 69826521D1 DE 69826521 T DE69826521 T DE 69826521T DE 69826521 T DE69826521 T DE 69826521T DE 69826521 D1 DE69826521 D1 DE 69826521D1
Authority
DE
Germany
Prior art keywords
group
pathogen inactivating
inactivating compound
red blood
pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69826521T
Other languages
English (en)
Other versions
DE69826521T2 (de
Inventor
David Cook
Adonis Stassinopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of DE69826521D1 publication Critical patent/DE69826521D1/de
Application granted granted Critical
Publication of DE69826521T2 publication Critical patent/DE69826521T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
DE69826521T 1998-01-06 1998-07-06 Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien Expired - Lifetime DE69826521T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7059798P 1998-01-06 1998-01-06
US70597P 1998-01-06
PCT/US1998/013931 WO1999034839A1 (en) 1998-01-06 1998-07-06 Methods for quenching pathogen inactivators in biological materials

Publications (2)

Publication Number Publication Date
DE69826521D1 true DE69826521D1 (de) 2004-10-28
DE69826521T2 DE69826521T2 (de) 2005-09-29

Family

ID=22096274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69826521T Expired - Lifetime DE69826521T2 (de) 1998-01-06 1998-07-06 Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien

Country Status (11)

Country Link
US (3) US6270952B1 (de)
EP (1) EP1045704B1 (de)
JP (2) JP4643004B2 (de)
CN (1) CN1203900C (de)
AT (1) ATE276771T1 (de)
AU (1) AU745209B2 (de)
CA (1) CA2317603A1 (de)
DE (1) DE69826521T2 (de)
ES (1) ES2224415T3 (de)
HK (1) HK1034682A1 (de)
WO (1) WO1999034839A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
AU745209B2 (en) * 1998-01-06 2002-03-14 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6369048B1 (en) 1998-01-12 2002-04-09 V.I. Technologies, Inc. Methods and compositions for inactivating viruses
US20030073650A1 (en) * 1998-07-21 2003-04-17 Heather Reddy Method and apparatus for inactivation of biological contaminants using photosensitizers
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
EP1284743A2 (de) * 2000-05-31 2003-02-26 Cerus Corporation Bereitung von pathogeninaktivierter lösung von roter blutzellen mit reduzierter immunität
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
CA2434256A1 (en) * 2000-12-21 2003-07-31 David Cook Methods for inactivation of pathogens in biological materials
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
US20030141260A1 (en) * 2001-12-28 2003-07-31 Frank Corbin Oxygen-enhanced pathogen inactivation
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US7235392B2 (en) * 2001-12-07 2007-06-26 The Ohio State University Research Foundation Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
EP1531823A4 (de) 2002-05-10 2007-07-18 Univ Ohio State Flavin n-oxide: neue krebsmittel und mittel zur beseitigung von erregern
EP1592441B1 (de) 2003-02-06 2012-04-11 Aduro Biotech Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
CA2515298C (en) 2003-02-06 2014-04-08 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
BRPI0518198B8 (pt) * 2004-10-29 2021-06-22 Cerus Corp método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit
KR101742533B1 (ko) 2008-04-09 2017-06-01 세루스 코포레이션 적혈구 병원체 불활성화를 위한 개선된 퀀칭 방법
JP2011523553A (ja) 2008-05-19 2011-08-18 アデュロ バイオテック ＰｒｆＡ＊変異株リステリアを含む組成物およびその使用法
EP2448603A1 (de) 2009-06-30 2012-05-09 3M Innovative Properties Company Lichtaktivierter antimikrobieller artikel und verfahren zu seiner verwendung
US7989593B1 (en) 2010-05-27 2011-08-02 Bing Lou Wong Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
US7932356B1 (en) 2010-06-23 2011-04-26 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition
US8048856B1 (en) 2010-06-23 2011-11-01 Billion King, Ltd. Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
US8084581B1 (en) 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20130052232A1 (en) 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking
EP3194576B1 (de) 2014-07-23 2020-11-18 Cerus Corporation Verfahren zur herstellung von thrombozyten-produkten
CN108135936A (zh) 2015-06-26 2018-06-08 塞鲁斯公司 冷沉淀物组合物及其制备方法
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
EA201991506A1 (ru) 2016-12-23 2020-01-23 Сирус Корпорейшн Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
EP3562493A1 (de) 2016-12-31 2019-11-06 Cerus Corporation Zusammensetzungen und verfahren zur herstellung von erythrozyten
US11235090B2 (en) 2017-03-03 2022-02-01 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018395525B2 (en) * 2017-12-29 2023-09-14 Cerus Corporation Systems and methods for treating biological fluids
MX2021003180A (es) * 2018-09-20 2021-05-14 Cerus Corp Métodos y kits para preparar sangre entera con inactivación de patógenos.
WO2020264421A1 (en) 2019-06-28 2020-12-30 Cerus Corporation System and methods for implementing a biological fluid treatment device

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281579A (en) * 1883-07-17 Electric valve
US2402665A (en) 1942-11-12 1946-06-25 Du Pont Chemical process
US2402655A (en) 1943-09-22 1946-06-25 Miller Pottery Engineering Co Pottery slip-casting apparatus
IT1093275B (it) 1978-01-26 1985-07-19 Snam Progetti Composizione adatta alla purificazione del sangue e suoi impieghi
US4337269A (en) 1979-07-23 1982-06-29 Sutton Laboratories, Inc. Preservative compositions
US4727027A (en) 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4748120A (en) 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5281579A (en) 1984-03-23 1994-01-25 Baxter International Inc. Purified virus-free hemoglobin solutions and method for making same
US4971760A (en) 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US4944920A (en) 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5055485A (en) 1988-12-02 1991-10-08 New York Blood Center, Inc. Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5753258A (en) 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
WO1993014791A2 (en) * 1992-01-27 1993-08-05 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
GB9218581D0 (en) 1992-09-02 1992-10-14 Pall Corp Removal of unwanted fluids from processed blood products
AU698154B2 (en) 1993-06-23 1998-10-22 New York Blood Center, Inc., The System for viral inactivation of blood
US5591350A (en) 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
SE9402472L (sv) * 1994-07-13 1996-01-14 Forskarpatent I Linkoeping Ab Modifierade ytor
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5660731A (en) 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US5637451A (en) 1995-03-29 1997-06-10 New York Blood Center, Inc. Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells
US6177441B1 (en) * 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
EP0773716A4 (de) * 1995-06-07 1999-08-04 Cerus Corp Behandlung von lösungen roter blutkörperchen mit antivralen wirkstoffen
ATE451445T1 (de) 1995-06-07 2009-12-15 Cerus Corp Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
AU703108B2 (en) * 1995-06-07 1999-03-18 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
AU7717396A (en) 1995-06-29 1997-02-05 Hemasure, Inc. Inactivation of pathogens using hydroxymethylamines
US6114108A (en) 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
US6136586A (en) 1995-08-29 2000-10-24 Vi Technologies, Inc. Methods for the selective modification of viral nucleic acids
AU723016B2 (en) 1995-11-06 2000-08-17 New York Blood Center, Inc., The Viral inactivation treatment of red blood cells using phthalocyanines and red light
WO1997018844A1 (en) 1995-11-21 1997-05-29 Pall Corporation Inactivation method and system in biological fluids
AU5620598A (en) * 1996-12-31 1998-07-31 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
WO1998030545A1 (en) * 1997-01-06 1998-07-16 Cerus Corporation Frangible compounds for pathogen inactivation
AU745209B2 (en) * 1998-01-06 2002-03-14 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US6150109A (en) 1999-01-25 2000-11-21 V. I. TECHNOLOGIES, Inc. Lipophilic quenching of viral inactivating agents
BRPI0518198B8 (pt) * 2004-10-29 2021-06-22 Cerus Corp método ex vivo para tratar uma composição de células hemácias para inativar um patógeno, se presente, bem como composição e kit

Also Published As

Publication number Publication date
US6709810B2 (en) 2004-03-23
JP2002500204A (ja) 2002-01-08
HK1034682A1 (en) 2001-11-02
DE69826521T2 (de) 2005-09-29
EP1045704B1 (de) 2004-09-22
AU8289198A (en) 1999-07-26
US20040180321A1 (en) 2004-09-16
US6270952B1 (en) 2001-08-07
CN1284886A (zh) 2001-02-21
CN1203900C (zh) 2005-06-01
EP1045704A1 (de) 2000-10-25
US7293985B2 (en) 2007-11-13
CA2317603A1 (en) 1999-07-15
JP4643004B2 (ja) 2011-03-02
US20020028432A1 (en) 2002-03-07
ES2224415T3 (es) 2005-03-01
WO1999034839A1 (en) 1999-07-15
AU745209B2 (en) 2002-03-14
ATE276771T1 (de) 2004-10-15
JP2010248245A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
DE69826521D1 (de) Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
HK1109594A1 (en) Improved quenching methods for red blood cell inactivation process
ATE210192T1 (de) VERFAHREN ZUR DIREKTEN SEQUENZIERUNG WÄHREND ßTEMPLATEß-AMPLIFIKATION
EP0668777A4 (de) Prostata-spezifisches membranantigen.
ATE191515T1 (de) Verfahren und zusammensetzungen zum analysieren von nukleinsäuremolekulen mittels bemessungstechniken
ES2180416A1 (es) Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
BR9815569A (pt) Método para extração de biomoléculas de material biológico
ES2182297T3 (es) Deteccion y modulacion de lo inhibidores de las proteinas de la apoptosis (iaps) y de los polipeptidos anti-apoptoticos afines (naip) para la diagnosis y tratamiento de enfermedades proliferativas.
EP1961826A3 (de) Verfahren zur direkten Sequenzierung von Nukleinsäuren
DE69607830D1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
ATE260988T1 (de) Vorrichtung und verfahren zur durchführung und überwachung von polymerase kettenreaktionen
DE59800705D1 (de) Vorrichtung zum automatischen durchführen von chemischen bzw. biologischen verfahren
DE69636122D1 (de) Verfahren zur einführung von genen in zielzellen mit hilfe von retroviren
DE69034061D1 (de) Methode der veränderung der expression von genen bei der transkription und zum nachweis von chemischen substanzen, die wie modulatoren der genexpression wirken
DE69524083T2 (de) Stoffen und verfahren zum nachweis von mycobakterium tuberculosis
DE602004031152D1 (de) Verfahren und system zum analysieren von reaktione
FI953990A (fi) Menetelmä nukleiinihappomonistusreaktiotuotteen tekemiseksi kykenemät-tömäksi olemaan lisämonistuksen kohteena, diagnostinen määritysmenetelmä, jossa tätä menetelmää käytetään, ja menetelmän tai määrityksen toteutukseen sopiva testipakkaus ja säiliö
NO870794L (no) FremgangsmŸte til kvantitativ bestemmelse av nukleinsyremolekyler og reagenspakke til bruk ved utfelse av fremgang smŸten.
DE69531487D1 (de) Methode zur eliminierung von sequenzierartefakten
DE59606129D1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
EP1083980A4 (de) Modulation molekularer wechselwirkungspositionen in rns und anderen biomolekülen
Kolpashchikov et al. Sensitized photomodification of mammalian DNA polymerase β. A new approach for highly selective affinity labeling of polymerases
DE69927400D1 (de) Pge synthase und verfahren und mitteln zur modulation deren aktivität
WO2001026536A3 (en) Methods of diagnosing and treating hepatic cell proliferative disorders
WO2001030986A3 (en) Human pif1 dna helicase and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition